Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations

NCT00633074 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A)
BIOLOGICAL: Thiomersal reduced FluAS25 adjuvanted vaccine (GSK576389A)

Sponsor

GlaxoSmithKline